These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
574 related articles for article (PubMed ID: 23706268)
1. Hypoxia induced CA9 inhibitory targeting by two different sulfonamide derivatives including acetazolamide in human glioblastoma. Said HM; Hagemann C; Carta F; Katzer A; Polat B; Staab A; Scozzafava A; Anacker J; Vince GH; Flentje M; Supuran CT Bioorg Med Chem; 2013 Jul; 21(13):3949-57. PubMed ID: 23706268 [TBL] [Abstract][Full Text] [Related]
2. Modulation of carbonic anhydrase 9 (CA9) in human brain cancer. Said HM; Supuran CT; Hageman C; Staab A; Polat B; Katzer A; Scozzafava A; Anacker J; Flentje M; Vordermark D Curr Pharm Des; 2010; 16(29):3288-99. PubMed ID: 20819065 [TBL] [Abstract][Full Text] [Related]
3. Expression patterns of the hypoxia-related genes osteopontin, CA9, erythropoietin, VEGF and HIF-1alpha in human glioma in vitro and in vivo. Said HM; Hagemann C; Staab A; Stojic J; Kühnel S; Vince GH; Flentje M; Roosen K; Vordermark D Radiother Oncol; 2007 Jun; 83(3):398-405. PubMed ID: 17524506 [TBL] [Abstract][Full Text] [Related]
4. Distinct patterns of hypoxic expression of carbonic anhydrase IX (CA IX) in human malignant glioma cell lines. Said HM; Staab A; Hagemann C; Vince GH; Katzer A; Flentje M; Vordermark D J Neurooncol; 2007 Jan; 81(1):27-38. PubMed ID: 16944313 [TBL] [Abstract][Full Text] [Related]
5. Rapid detection of the hypoxia-regulated CA-IX and NDRG1 gene expression in different glioblastoma cells in vitro. Said HM; Polat B; Staab A; Hagemann C; Stein S; Flentje M; Theobald M; Katzer A; Vordermark D Oncol Rep; 2008 Aug; 20(2):413-9. PubMed ID: 18636206 [TBL] [Abstract][Full Text] [Related]
6. DNA damage is a prerequisite for p53-mediated proteasomal degradation of HIF-1alpha in hypoxic cells and downregulation of the hypoxia marker carbonic anhydrase IX. Kaluzová M; Kaluz S; Lerman MI; Stanbridge EJ Mol Cell Biol; 2004 Jul; 24(13):5757-66. PubMed ID: 15199132 [TBL] [Abstract][Full Text] [Related]
7. Regulation of pH by Carbonic Anhydrase 9 Mediates Survival of Pancreatic Cancer Cells With Activated KRAS in Response to Hypoxia. McDonald PC; Chafe SC; Brown WS; Saberi S; Swayampakula M; Venkateswaran G; Nemirovsky O; Gillespie JA; Karasinska JM; Kalloger SE; Supuran CT; Schaeffer DF; Bashashati A; Shah SP; Topham JT; Yapp DT; Li J; Renouf DJ; Stanger BZ; Dedhar S Gastroenterology; 2019 Sep; 157(3):823-837. PubMed ID: 31078621 [TBL] [Abstract][Full Text] [Related]
8. HIF-1α inhibition by siRNA or chetomin in human malignant glioma cells: effects on hypoxic radioresistance and monitoring via CA9 expression. Kessler J; Hahnel A; Wichmann H; Rot S; Kappler M; Bache M; Vordermark D BMC Cancer; 2010 Nov; 10():605. PubMed ID: 21050481 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of hypoxia-inducible carbonic anhydrase-IX enhances hexokinase II inhibitor-induced hepatocellular carcinoma cell apoptosis. Yu SJ; Yoon JH; Lee JH; Myung SJ; Jang ES; Kwak MS; Cho EJ; Jang JJ; Kim YJ; Lee HS Acta Pharmacol Sin; 2011 Jul; 32(7):912-20. PubMed ID: 21666701 [TBL] [Abstract][Full Text] [Related]
10. Extracellular acidosis elevates carbonic anhydrase IX in human glioblastoma cells via transcriptional modulation that does not depend on hypoxia. Ihnatko R; Kubes M; Takacova M; Sedlakova O; Sedlak J; Pastorek J; Kopacek J; Pastorekova S Int J Oncol; 2006 Oct; 29(4):1025-33. PubMed ID: 16964400 [TBL] [Abstract][Full Text] [Related]
11. Imaging the hypoxia surrogate marker CA IX requires expression and catalytic activity for binding fluorescent sulfonamide inhibitors. Dubois L; Douma K; Supuran CT; Chiu RK; van Zandvoort MA; Pastoreková S; Scozzafava A; Wouters BG; Lambin P Radiother Oncol; 2007 Jun; 83(3):367-73. PubMed ID: 17502120 [TBL] [Abstract][Full Text] [Related]
12. Sulfonamide derivative targeting carbonic anhydrase IX as a nuclear imaging probe for colorectal cancer detection in vivo. Guan SS; Cheng CC; Ho AS; Wang CC; Luo TY; Liao TZ; Chang J; Wu CT; Liu SH Oncotarget; 2015 Nov; 6(34):36139-55. PubMed ID: 26447758 [TBL] [Abstract][Full Text] [Related]
13. Src induces expression of carbonic anhydrase IX via hypoxia-inducible factor 1. Takacova M; Holotnakova T; Barathova M; Pastorekova S; Kopacek J; Pastorek J Oncol Rep; 2010 Mar; 23(3):869-74. PubMed ID: 20127031 [TBL] [Abstract][Full Text] [Related]
14. Identification of carbonic anhydrase 9 as a contributor to pingyangmycin-induced drug resistance in human tongue cancer cells. Zheng G; Zhou M; Ou X; Peng B; Yu Y; Kong F; Ouyang Y; He Z FEBS J; 2010 Nov; 277(21):4506-18. PubMed ID: 21040473 [TBL] [Abstract][Full Text] [Related]
15. Carbonic anhydrase inhibitors. Design of fluorescent sulfonamides as probes of tumor-associated carbonic anhydrase IX that inhibit isozyme IX-mediated acidification of hypoxic tumors. Cecchi A; Hulikova A; Pastorek J; Pastoreková S; Scozzafava A; Winum JY; Montero JL; Supuran CT J Med Chem; 2005 Jul; 48(15):4834-41. PubMed ID: 16033263 [TBL] [Abstract][Full Text] [Related]
16. Targeting tumor-associated carbonic anhydrase IX in cancer therapy. Thiry A; Dogné JM; Masereel B; Supuran CT Trends Pharmacol Sci; 2006 Nov; 27(11):566-73. PubMed ID: 16996620 [TBL] [Abstract][Full Text] [Related]
17. Genetic disruption of the pHi-regulating proteins Na+/H+ exchanger 1 (SLC9A1) and carbonic anhydrase 9 severely reduces growth of colon cancer cells. Parks SK; Cormerais Y; Durivault J; Pouyssegur J Oncotarget; 2017 Feb; 8(6):10225-10237. PubMed ID: 28055960 [TBL] [Abstract][Full Text] [Related]
19. Alternative splicing variant of the hypoxia marker carbonic anhydrase IX expressed independently of hypoxia and tumour phenotype. Barathova M; Takacova M; Holotnakova T; Gibadulinova A; Ohradanova A; Zatovicova M; Hulikova A; Kopacek J; Parkkila S; Supuran CT; Pastorekova S; Pastorek J Br J Cancer; 2008 Jan; 98(1):129-36. PubMed ID: 18026188 [TBL] [Abstract][Full Text] [Related]
20. Role of carbonic anhydrase IX in human tumor cell growth, survival, and invasion. Robertson N; Potter C; Harris AL Cancer Res; 2004 Sep; 64(17):6160-5. PubMed ID: 15342400 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]